In our previous study, all six PRDXs isoforms have been examined in paired cancer and non-cancer tissues by Immunohistochemistry and Western blotting, and the results showed that stage III patients and those cases with lymph node metastasis has a higher expression of PRDX2 [37]. Here, PRDX2 is linked to metastatic malignant neoplasm in the lymph nodes.